Clinical trial
Aerosolized Versus Intravenous Colistin-based Antimicrobial Regimens in Hospitalized COVID-19 Patients With Bacterial Coinfection: A Randomized Controlled Trial
NCT05689229 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aerosolized Versus Intravenous Colistin-based Antimicrobial Regimens in Hospitalized COVID-19 Patients With Bacterial Coinfection: A Randomized Controlled Trial
- Lead sponsor
- Beni-Suef University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 3, 2021
- Completion date
- December 12, 2021
- Enrollment
- 128 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
secondary bacterial infection in covid-19 patients